Literature DB >> 32153671

Total Pancreatectomy: Indications, Advantages and Disadvantages - A Review.

Danilo Coco1, Silvana Leanza2, Francesco Guerra1.   

Abstract

Background: Total pancreatectomy is an obligatory surgical procedure in locally advanced or centrally located pancreatic neoplasms to achieve complete tumour clearance. Owing to sound understanding of tumour biology and evolution in intervention technique and improved postoperative care, nowadays the indications of total pancreatectomy have taken a significant change. Aim: To review the indications of total pancreatectomy and its advantages and disadvantages under current perspectives. Method: Major databases, including PubMed, EMBASE, Science Citation Index Expanded, Scopus and the Cochrane Library, were searched for studies of total pancreatectomy and the results reported by various authors were summarized.
Results: The indications of total pancreatectomy in subjects diagnosed with chronic pancreatitis were classified into four subgroups, including "Tumour", "Trouble", "Technical difficulties" and "Therapy-refractory pain". Today, total pancreatectomy has more specific and different indications than before. Currently, IPMN (intraductal papillary mucinous neoplasm) seems to have the most essential indication quantitatively. Morbidity and mortality related to total pancreatectomy are more profoundly decreased than before due to improvements in the operative techniques and post-operative managements. Some of the metabolic disorders are reported as major disadvantages of total pancreatectomy.
Conclusion: Despite the disadvantages of total pancreatectomy, it remains an inevitable procedure for subjects with chronic pancreatitis, improvements in operative techniques and postoperative management ensuring long-term survival, a better quality of life, and diminished mortality and morbidity rates.

Entities:  

Year:  2019        PMID: 32153671      PMCID: PMC7035443          DOI: 10.26574/maedica.2019.14.4.391

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  55 in total

1.  Total pancreatectomy of end-stage chronic pancreatitis.

Authors:  J W Braasch; L Vito; F W Nugent
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

2.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

3.  Incidence and management of pancreatic leakage after pancreatoduodenectomy.

Authors:  S M M de Castro; O R C Busch; T M van Gulik; H Obertop; D J Gouma
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

4.  Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?

Authors:  Brian J Billings; John D Christein; William S Harmsen; Jeffrey R Harrington; Suresh T Chari; Florencia G Que; Michael B Farnell; David M Nagorney; Michael G Sarr
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

Review 5.  Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

Authors:  H G Smeenk; T C K Tran; J Erdmann; C H J van Eijck; J Jeekel
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

6.  Impact of total pancreatectomy: short- and long-term assessment.

Authors:  Louise Barbier; Wisam Jamal; Safi Dokmak; Béatrice Aussilhou; Olivier Corcos; Philippe Ruszniewski; Jacques Belghiti; Alain Sauvanet
Journal:  HPB (Oxford)       Date:  2013-01-29       Impact factor: 3.647

7.  Analysis of mortality rates for pancreatic cancer across the world.

Authors:  D Hariharan; A Saied; H M Kocher
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

8.  Diabetic control after total pancreatectomy.

Authors:  P Jethwa; M Sodergren; A Lala; J Webber; J A C Buckels; S R Bramhall; D F Mirza
Journal:  Dig Liver Dis       Date:  2006-03-09       Impact factor: 4.088

9.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Authors:  John P Neoptolemos; Deborah D Stocken; Helmut Friess; Claudio Bassi; Janet A Dunn; Helen Hickey; Hans Beger; Laureano Fernandez-Cruz; Christos Dervenis; François Lacaine; Massimo Falconi; Paolo Pederzoli; Akos Pap; David Spooner; David J Kerr; Markus W Büchler
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

10.  The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials.

Authors:  J Gaedcke; B Gunawan; M Grade; R Szöke; T Liersch; H Becker; B M Ghadimi
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

View more
  1 in total

1.  Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy after Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?

Authors:  Ji-Hye Jung; So-Jeong Yoon; Ok-Joo Lee; Sang-Hyun Shin; Jin-Seok Heo; In-Woong Han
Journal:  Curr Oncol       Date:  2022-07-27       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.